An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions
Clinical trial NCT06671405 · COMPLETED
Trial details
- NCT number
- NCT06671405
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-25
- Primary completion
- 2025-02-17
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.